These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28805765)

  • 1. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammatory markers in Alzheimer's disease and vascular dementia].
    Androsova LV; Mikhaĭlova NM; Zozulia SA; Dupin AM; Rassadina GA; Lavrent'eva NV; Kliushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):49-53. PubMed ID: 23528583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia.
    Hazen J; Vistnes M; Barca ML; Eldholm RS; Persson K; Brækhus A; Saltvedt I; Selbæk G; Engedal K; Knapskog AB
    Alzheimer Dis Assoc Disord; 2020; 34(1):47-53. PubMed ID: 31414991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
    Parker DC; Mielke MM; Yu Q; Rosenberg PB; Jain A; Lyketsos CG; Fedarko NS; Oh ES
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):149-54. PubMed ID: 22539447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Scarabino D; Broggio E; Gambina G; Corbo RM
    Exp Gerontol; 2017 Nov; 98():143-147. PubMed ID: 28827085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid inflammatory markers in amnestic mild cognitive impairment.
    Rizzi L; Roriz-Cruz M
    Geriatr Gerontol Int; 2017 Feb; 17(2):239-245. PubMed ID: 26818250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of cluster analysis and logistic regression for assessing the risk of Alzheimer's disease in patients with mild cognitive impairment, amnestic type].
    Simonov AN; Klyushnik TP; Androsova LV; Mikhailova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12):40-43. PubMed ID: 30698559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
    Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
    J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease.
    Rui W; Xiao H; Fan Y; Ma Z; Xiao M; Li S; Shi J
    J Neuroinflammation; 2021 Dec; 18(1):280. PubMed ID: 34856990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantification of the relationship between inflammatory markers and Alzheimer's disease].
    Simonov AN; Klyushnik TP; Androsova LV; Mikhaylova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):58-63. PubMed ID: 29927405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease.
    Vasantharekha R; Priyanka HP; Swarnalingam T; Srinivasan AV; ThyagaRajan S
    Geriatr Gerontol Int; 2017 Oct; 17(10):1737-1745. PubMed ID: 27921357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.